alkeran 50mg powder and solvent for solution for injection vials
aspen pharma trading ltd - melphalan hydrochloride - powder and solvent for solution for injection - 50mg
melphalan medac 50 mg powder and solvent for solution for injection/infusion
medac gesellschaft für klinische spezialpräparate mbh - melphalan - powder and solvent for solution for injection/infusion - 50 milligram(s) - melphalan
melphalan tillomed 50 mg inj./inf. sol. (pwdr. + solv.) i.v./i.arter. vial
tillomed pharma gmbh - melperone hydrochloride 55,973 mg - eq. melphalan 50 mg - powder and solvent for solution for injection/infusion - 50 mg - melperone hydrochloride 55.973 mg - melphalan
alkeran- melphalan tablet, film coated
apopharma usa, inc. - melphalan (unii: q41or9510p) (melphalan - unii:q41or9510p) - melphalan 2 mg - alkeran tablets are indicated for the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary. alkeran should not be used in patients whose disease has demonstrated a prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.
apo-melphalan melphalan (as hydrochloride) 50 mg powder for injection glass vial with diluent
arrotex pharmaceuticals pty ltd - melphalan hydrochloride, quantity: 55.97 mg (equivalent: melphalan, qty 50 mg) - injection, powder for - excipient ingredients: povidone; hydrochloric acid - melphalan injection is indicated for the treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
alkeran solution
aspen pharmacare canada inc. - melphalan (melphalan hydrochloride); buffer solution - solution - 50mg; 10ml - melphalan (melphalan hydrochloride) 50mg; buffer solution 10ml - antineoplastic agents
melphalan pharmexon 50 mg powder and solvent for solution for injection/infusion
pharmexon consulting s.r.o - melphalan hydrocholoride - powder and solvent for solution for injection/infusion - 50 milligram(s) - nitrogen mustard analogues; melphalan
melphalan tillomed 50 mg powder and solvent for solution for injection/infusion
tillomed pharma gmbh - melphalan hydrochloride - powder and solvent for solution for injection/infusion - 50 milligram(s) - nitrogen mustard analogues; melphalan
melphalan hydrochloride kit
athenex pharmaceutical division, llc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.
melphalan hydrochloride kit
avenacy inc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.